|Day Low/High||49.43 / 50.85|
|52 Wk Low/High||28.33 / 77.03|
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
These names are showing both technical and quantitative deterioration.
That's the question my wife asked me recently -- here's my answer.
It's no secret that the Fed would like to get out of the short-term repo business.
Chinese President Xi Jinping, not a man given to exaggerate, has referred to the spread of this coronavirus in China as 'a grave situation.'
I do think that this Fed Chair has learned to be cautious, in reflection of the policy errors made in late 2018.
* Only three of eleven S&P sectors are viewed as attractive * I am in a risk off state of mind. Back in 2015 I instituted a new regular feature called "Sectors," in which I periodically offered my short-term (6-12 months) price outlook for each of t...
The Fed chairman's news conference threw markets for a loop with hawkish words that did not support the Fed's dovish actions.
The problem is that the Fed's mission has moved beyond their mandate.
Recently spun off Dow Inc. sports an attractive dividend yield and valuation.
The endless rally needs fuel, and without it, you end up with what you got Tuesday, a soggy session that was hit from the cloud, Beyond Meat's chill, and big merger uncertainties.
Mr. Market re-embraces the cyclicals today ( , , , etc.). This may support the notion that I am on the right track with my bond short.
I have received a number of questions about weightings and trading around positions. I recently posted this explanation in our Comments Section: In recognition that there is more uncertainty about market outcomes and that there are agents such as ET...
Bayer's takeover of Monsanto is expected to receive extra scrutiny out of fears the deal could prove detrimental for European farmers.
There are two separate and positive developments at Allergan over the last three days that should continue to buoy its shares, which were up $6 on Friday. First, as I posted over the weekend: Allergan and the Tribe Have Spoken Sep 9, 2017 ' 9:29 AM...
My investing methodology is anticipatory rather than reactionary because I base trades on my fair market value calculations instead of price trends.
Should investors and traders be reactionary by following and trusting stock prices, or should they be anticipatory and take advantage of the difference between stock prices and a derived calculation of intrinsic value? To me, one of the most difficu...
I added to my short exposure with add ons to longs ProShares UltraShort QQQ ETF and ProShares Trust UltraPro Short QQQ ETF and to iShares Russell 2000 ETF short. Bidding for SPDR S&P 500 ETF Trust puts -- short dated. Reduced Hartford Financial ...
Hear me out: The same lessons and disciplines are useful in both.
What's next for Dow Chemical CEO Andrew Liveris?
"Beware of false prophets, which come to you in sheep's clothing, but inwardly they are ravening wolves." -- Matthew 7:15-20 Am I the last short standing? Examining reward vs risk in the church of what is working now. I have seen this enthusias...
Yesterday's market advance was likely a function of a more dovish Janet Yellen (delivered without comment). It is clear that the Fed has no clue of where its neutral rate is. I continue to believe that domestic economic growth and corporate profit e...